Clinical Trials Browser

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Clinical Trials

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Okgyn1

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

First In Human Study of CX-2051 in Advanced Solid Tumors

A Study of TIL in Advanced Solid Tumors (CZ)

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

EPRAD

MEDIPAC

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

NeoTIL in Advanced Solid Tumors

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

A Study of CS1002 in Subjects with Advanced Solid Tumors

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

First In Human Study of CX-801 in Advanced Solid Tumors

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

RACIN

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

FCN-437c

Absorption and Excretion of Oral Docetaxel

Phase 1a Study to Evaluate Immunogenicity of ASV®

Food Effect Study of ModraDoc006 in Combination With Ritonavir

A Study of of HOT1030 in Patients With Advanced Solid Tumors

GATTO

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

HDAC6i

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors